Skip to Main Content

Resource Type

News

Blog

December 16, 2021

PET/CT with Pylarify available at ARA

A PARADIGM SHIFT IN IDENTIFYING PROSTATE CANCER ARA is excited to offer a revolutionary radiotracer for the identification of prostate cancer. PET/CT...

Blog

June 15, 2021

ARA to offer prostate cancer imaging agent Pylarify pending CMS approval

FDA APPROVES PYLARIFY AS FIRST AND ONLY COMMERCIALLY AVAILABLE PSMA PET IMAGING AGENT FOR PROSTATE CANCER On May 27, 2021, Lantheus...

Blog

June 15, 2021

CMS approval expected for Amyvid after FDA approval of aducanumab treatment for Alzheimer’s Disease

AMYVID FOR ALZHEIMER’S DIAGNOSIS In 2012, the FDA approved Amyvid (florbetapir F 18), a radiopharmaceutical for use in PET imaging of...

Blog

October 22, 2020

What you need to know about mammography

by Dr. Arthy Saravanan Mammograms save lives. The key message that we try to convey regarding breast cancer awareness is that...

Blog

July 22, 2020

I got a CT calcium scoring exam. I’m so glad!

by Julia Austin ARA Marketing Team I’m really glad I got a CT calcium scoring exam for coronary artery disease (CAD)....

Blog

July 29, 2019

ARA Neurointerventional Surgeon Is First in Austin to Use PulseRider Device

Basilar tip aneurysms have a reputation for being hard to treat. When an Austin-area patient recently presented with this type of...

Blog

July 29, 2019

ARA First in Central Texas to Offer SpineJack Treatment

One of ARA Diagnostic Imaging’s neurointerventional surgeons, Dr. Kirk Conrad, performed the first implantation in Central Texas of the leading-edge SpineJack...

Blog

July 13, 2017

Men’s Health Screenings at ARA

Catching a health issue early really makes a big difference in how it's treated. So, screenings really are very important because...

Pagination forPage of

Masks Required

For the protection of patients and staff, ARA requires everyone who enters our imaging centers to wear a mask.

Close Icon
Back to Top
Technical Assistance